Novel dopamine receptor 3 antagonists inhibit the growth of primary and temozolomide resistant glioblastoma cells.
Williford SE, Libby CJ, Ayokanmbi A, Otamias A, Gordillo JJ, Gordon ER, Cooper SJ, Redmann M, Li Y, Griguer C, Zhang J, Napierala M, Ananthan S, Hjelmeland AB.
Williford SE, et al. Among authors: gordillo jj.
PLoS One. 2021 May 4;16(5):e0250649. doi: 10.1371/journal.pone.0250649. eCollection 2021.
PLoS One. 2021.
PMID: 33945569
Free PMC article.